Your browser doesn't support javascript.
COVID-19 in Children.
Zachariah, Philip.
  • Zachariah P; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, USA. Electronic address: pz2177@cumc.columbia.edu.
Infect Dis Clin North Am ; 36(1): 1-14, 2022 03.
Article in English | MEDLINE | ID: covidwho-2130977
ABSTRACT
Although COVID-19 has impacted many children, severe disease is rare and most recover with supportive care. Manifestations are diverse and often nonrespiratory. Adolescents/children with medical comorbidities are at risk for severe respiratory compromise. The most serious manifestation in previously healthy children is a delayed multisystem inflammatory syndrome with cardiac compromise in severe cases. Anti-SARS-CoV-2 monoclonal antibodies are available for adolescents at risk of progression and not hospitalized. Therapeutic options for severe respiratory disease with hypoxia include remdesivir and glucocorticoids. Therapies for multisystem inflammatory syndrome in children include intravenous immunoglobulin and glucocorticoids. Refractory cases may benefit from additional immunomodulators.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid / Variants Limits: Adolescent / Child / Humans Language: English Journal: Infect Dis Clin North Am Journal subject: Communicable Diseases Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid / Variants Limits: Adolescent / Child / Humans Language: English Journal: Infect Dis Clin North Am Journal subject: Communicable Diseases Year: 2022 Document Type: Article